La. Stat. tit. 40 § 2025.5

Current with changes from the 2024 Legislative Session
Section 40:2025.5 - Access to information; confidentiality
A. Notwithstanding any other provision of law to the contrary, on written request of the chair of an overdose fatality review panel and as necessary to carry out the purpose and duties of the review panel, the panel shall be authorized to have access to the following information:
(1) Information and records regarding the physical health, mental health, and treatment for substance use disorder, maintained by a healthcare provider, substance use disorder treatment provider, hospital, or health system for an individual whose death or near death is being reviewed by the review panel.
(2) Information and records maintained by a state or local government agency or entity, including but not limited to death investigative information, medical examiner investigative information, law enforcement investigative information, emergency medical services reports, fire department records, prosecutorial records, parole and probation information and records, court records, school records, and information and records of the Department of Children and Family Services if the agency or entity provided services to:
(a) An individual whose death or near death is being reviewed by the review panel.
(b) The family of the decedent being investigated.
B. A person or entity subject to a records request by a review panel pursuant to this Section may charge the review panel a reasonable fee for the service of duplicating any records requested by the panel.
C. The chair of the review panel, or the chair's designee, may request the individual whose overdose is under review or, if deceased, the individual's next of kin, to sign a consent form for the release of confidential information.
D. An individual, entity, or local or state agency that in good faith provides information or records to the local panel shall not be subject to civil or criminal liability or any professional disciplinary action as a result of providing the information or record.
E. A member of a review panel may contact, interview, or obtain information by request from a family member or friend of an individual whose death is being reviewed by the panel.
F. Information and records obtained by the review panel in accordance with the provisions of this Section and the results of any overdose fatality review report shall be confidential and shall not be available for subpoena nor shall the information be disclosed, discoverable, or compelled to be produced in any civil, criminal, administrative, or other proceeding, nor shall the records be deemed admissible as evidence in any civil, criminal, administrative, or other tribunal or court of any reason. Information and records presented to the review panel shall not be immune from subpoena, discovery, or prohibited from being introduced into evidence solely because they were presented to or reviewed by the review panel if the information and records have been obtained from other sources.
G. Any person, agency, or entity furnishing information, documents, and reports in accordance with this Section shall not be liable for the disclosure and shall not be considered in violation of any privileged or confidential relationship, if the person, agency, or entity has acted in good faith in the reporting pursuant to this Section.
H. A member of the review panel shall not disclose any information that is confidential under this Section. A person who appears before, participates in, or provides information to the review panel shall sign a confidentiality notice to acknowledge that any information he provides to the review panel shall be confidential. Information identifying an overdose victim whose case is being reviewed, or that victim's family members, or regarding the involvement of any agency with the victim or victim's family members, shall not be disclosed in any report that is available to the public. Nothing in this Section shall prohibit the publishing by the review panel of statistical compilations relating to overdose fatalities which do not identify a person's case or a person's healthcare provider, law enforcement agency, or organization who provides services to victims.
I. When the review panel concludes a review of an overdose fatality or other review, it shall return all information and records that concern a victim or the victim's family members to the person, agency, or entity that furnished the information.

La. R.S. § 40:2025.5

Added by Acts 2024, No. 498,s. 1, eff. 8/1/2024.